Inhibitory effects of bromoindoles on Escherichia coli O157:H7 biofilms

Enterohemorrhagic Escherichia coli O157:H7 (EHEC) is responsible for outbreaks of hemorrhagic colitis worldwide, but no effective therapy exists for EHEC infections. EHEC readily forms antimicrobial-tolerant biofilms on various biotic and abiotic surfaces. Here, we investigated the antimicrobial and antibiofilm abilities of 16 halogenated (fluoro-, chloro-, bromo-, or iodo-) indoles and indole against a pathogenic EHEC strain. Antibiofilm activities followed the order chloroindoles > bromoindoles > indole > fluoroindoles. For example, the minimum inhibitory concentrations (MICs) of 4-bromoindole and 5-bromoindole were 100 and 200 mu g/mL, respectively, and at 20 mu g/mL, they both inhibited EHEC biofilm formation by more than 61% without affecting planktonic cell growth. However, at concentrations greater than their MICs, both showed bactericidal activity. Antibiofilm effects were confirmed by scanning electron microscopy. Both 4-bromoindole and 5-bromoindole reduced swimming and swarming motility and curli formation, which are important factors for EHEC biofilm formation. Furthermore, quantitative structure-activity relationship analysis demonstrated that halogenation of indole with chlorine, bromine, or iodine at positions C-4 or C-5 promotes antimicrobial activity but that substitution at C-7 is detrimental. The study shows that halogenated indoles, particularly bromoindoles, have potential use as antimicrobial and antibiofilm therapies against EHEC.